Ventricular Arrhythmia Complicating Treatment with Hydroxychloroquine and Azithromycin in a Covid-19 Patient

Authors: Benouna El Ghali M, Aqli M, Badaoui K, Arous S, Benmallem O, Ech-chenbouli A, Bendahou H, Habbal R, Aissaoui O*, Berrada L, Salmi S, EL Kettani C, Barrou L and Afif H

DOI: 10.23880/mjccs-16000S1-001

Special Issue 1: Advance Studies of COVID-19

Abstract

Hydroxychloroquine, used alone or in combination with Azithromycin for the treatment of Covid-19, is known theoretically by its cardiotoxicity and the occurrence of ventricular arrhythmias. We report here the observation of a 19-year-old patient diagnosed with Covid-19 and who developed a Torsades de pointe after three days of treatment with Hydroxychloroquine and Azithromycin in combination. The hydro electrolytic assessment, in the course of time, had shown a slight hypomagnesemia. Conclusion: Monitoring of ionic blood disorders and the EKG on a regular basis is necessary to monitor Covid-19 patients to avoid ventricular arrhythmias.

Keywords: COVID-19; Peripartum Cardiomyopathy; Hydroxychloroquine

View PDF